Background: Huntington's disease (HD) is caused by an unstable polyglutamine
Introduction
Huntington's disease is a fatal, progressive neurodegenerative disorder caused by an unstable polyglutamine (CAG) expansion in the gene coding for the protein huntingtin. It is characterised by motor dysfunction, notably chorea, as well as cognitive, psychiatric and sleep abnormalities. Death typically occurs 12-15 years from the first symptoms [1] . HD pathology is characterised by striatal and cortical neurodegeneration that is accompanied by the presence of aggregates of mutant huntingtin. These aggregates have been found in the nucleus and cytoplasm of both humans [2] and mouse models of HD [3, 4] . The precise role of the inclusions in disease development has yet to be resolved.
The expanded CAG repeat that causes HD is inherently unstable. In both HD patients and mouse models, somatic variation in CAG repeat number affects both age at onset and severity of the disease symptoms. An expansion of [35] [36] [37] repeats is sufficient to cause HD [5] , and longer repeats correlate with earlier age at onset of symptoms [6] . However, variability in age of onset is only partly explained by the number of CAG repeats, indicating that other factors are involved [7] . It has been suggested that in HD patients' brains, somatic CAG repeat expansion occurs until the repeat length reaches a pathological threshold [8] . Therefore, the age of onset of HD is dependent upon both the initial length of the CAG repeat, and the time it takes for the unstable expansions to reach the toxic threshold. This fits with evidence from studies showing that individuals carrying HD gene mutations are overtly neurologically normal until phenoconversion [9, 10] . Even so, results from the PREDICT-HD and TRACK-HD initiative show that brain volume loss can be detected up to 10 years before symptoms become manifest, suggesting a long-term, insidious, process of neuronal loss that only gradually produces any clinical signs [11] [12] [13] [14] . However, evidence is accumulating to show that subtle cognitive impairment may also be present in HD patients for some years before diagnosis, suggesting that the mismatch between onset of brain changes and detection of symptoms may be partly due to incomplete diagnostic criteria [15] [16] [17] .
Most mouse models of HD have, by comparison with humans, very long CAG repeat lengths (typically in the range 110-250). This is well-recognised in the field to be a caveat to the appropriateness of the models. However, the need for greater initial repeat lengths in mice may be explained by the Kaplan model [8] , which predicts that unstable expansions need to reach a toxic threshold of ~115 CAGs before pathology is seen. The life span of a mouse (approximately 2 years) may be insufficient to allow a pathology-inducing expansion to be reached from a short inherited CAG repeat length in the range that causes disease in humans.
We have previously reported that there are considerable age differences in the onset of abnormal phenotype in the R6/2 transgenic mouse model of HD, with the relationship between age and CAG repeat length being U-shaped. As the number of CAG repeats increases past 200, so does life span [18] . Furthermore, the timing of appearance of the classically described neuronal intranuclear inclusions (NII) [19] is delayed in mice with >300 CAG repeats [18] . These findings were similar to those of Dragatsis and colleagues, who found an extended lifespan in mice carrying 300-400 repeats [20] . The idea that longer CAG repeats cause disease with a slower trajectory has also been supported by electrophysiological studies [21] .
We were interested in investigating the consequences of longer repeat lengths on structural changes in the brains of R6/2 mice, especially with regard to the progressive atrophy that characterises HD. We used a mixed longitudinal and cross-sectional experimental design to compare structural and biochemical changes in lines of R6/2 mice carrying 250 or 350 CAG repeats using in vivo high-resolution magnetic resonance imaging (MRI) and spectroscopy (MRS). The advantage of this non-invasive method is that a detailed trajectory of morphological changes can be monitored longitudinally without the need to sacrifice large numbers of animals at each time point. Automated voxel-based morphometry has proved a sensitive method for identifying morphological differences in mouse models of HD both in vivo [22] and ex vivo [23] .
Materials and Methods

Mice
All procedures were conducted in accordance with the UK Animals (Scientific Procedures) Act 1986, and were approved by the University of Cambridge Animal Welfare and Ethical Review Board.
Mice were taken from colonies of R6/2 mice established in the University of Cambridge, and maintained by backcrossing onto CBA x C57BL6 F1 female mice.
Methods for the genotyping of these mice, and details of the animal husbandry, have been described previously [3, 24] . Briefly, mice were housed in single-sex, singlegenotype groups of 3-4 at 21-23°C with humidity of 55 ± 10%. Lowered waterspouts were provided for ad libitum access to water and standard dry laboratory food was given. A supplementary feed (of mash made by soaking 100g dry food in 230 ml of filtered tap water until pellets were soft and fully expanded) was given each morning and evening. Enrichment was provided by the addition of plastic houses, cardboard tubes and chew blocks to the cages. Genotyping and CAG repeat length measurement were carried out by Laragen (Los Angeles, CA, USA). We selected 
Image acquisition
Mice were anaesthetised with isoflurane (1-2% in 1l/min O 2 ). Respiration rates were measured using a pressure-sensor (SA Instruments, Stony Brook, NY, USA). Depth of anaesthesia was adjusted according to the respiration rate to maintain a consistent level between mice. Body temperature was measured with a rectal probe and maintained in the normal range using a heated flowing-water blanket.
Structural Imaging
Mice were scanned at 4.7T using a Bruker BioSpec 47/40 system (Bruker Inc., Ettlingen, Germany). An actively-decoupled birdcage transmitter (model T5346) was used for excitation, and the manufacturer-provided quadrature mouse head surface coil (model T9788) was used for signal reception. Structural imaging was achieved with a rapid acquisition with relaxation enhancement (RARE) sequence (scan parameters: repetition time 3.5s, effective echo time 32ms, bandwidth 40 kHz, echo train length 12, field of view 25.6×19.2×10.0mm 3 , matrix 256×192×100). The final resolution was 100µm isotropic, and images were acquired in 1 hour 33 minutes.
Magnetic resonance spectroscopy
Following structural imaging, a point-resolved selective spectroscopy (PRESS) voxel was positioned at the level of the left caudate putamen. The voxel extended 2mm in each direction (8µl) and was acquired with 128 transients with a repetition time of 2.5s and echo time 20ms. Water suppression was achieved with the variable power and optimized relaxation (VAPOR) scheme with manually-adjusted pulse power and localised shimming was performed using the manufacturer-provided FASTMAP routine with a 4mm cubic voxel centred on the smaller PRESS region. Outer volume suppression was enabled and a navigator signal was acquired for retrospective frequency locking.
MR data analysis
Tensor-based morphometry
Tensor-based morphometry (TBM) was performed using SPM8 (Wellcome Trust
Centre for Neuroimaging, UCL) with the DARTEL registration software [25] modified for mice using the SPMMouse toolbox.
Images were aligned manually with the mouse template created during our previous voxel-based morphometry study [26] and segmented using unified segmentation [27] . DARTEL was used with the settings we have described previously [22] to produce maps of local volume change (Jacobian determinants).
We used the maps in three different ways. Firstly, we compared separately the local volume differences from R6/2 250 CAG mice or R6/2 350 CAG mice with those of WT mice at the age of 12-15 weeks, and also compared male with female mice in all three groups. Determinant maps were smoothed by a 400µm isotropic Gaussian smoothing kernel. To control for the type I errors expected due to multiple comparisons, a false-discovery rate of q < 0.05 was used [28] . This correction means one can expect that, on average, 5% of the findings reported as significant will be false positives. Secondly, for visual comparison, we produced maps showing the mean difference between the Jacobian determinant of WT and R6/2 mice of each genotype at 8-12 weeks and for each 3 week block thereafter, as long as at least 4 mice survived per group (until 21 weeks in 250 CAG mice and 33 weeks in 350 CAG mice). Thirdly, we extracted mean determinants within regions of interest (ROI) [29] for each mouse at each time point to compare trajectories of change over time for each genotype. We measured the caudate putamen, cerebral cortex, lateral ventricles, internal capsule, hippocampal formation and amygdaloid nucleus. To compare rates of change, linear regression lines were calculated using Matlab R2014 (MathWorks, Cambridge, MA, USA) and statistical significance of regression slopes was assessed using permutation testing, preserving animal age though randomly permuting genotype labels. We first looked for sex differences in rates of volume change of the localised structures, and where none were present, data from male and female mice were combined for further analysis as described above.
Spectroscopy analysis
Spectra were analysed using basis functions with LCModel version 6.3 [30] from 4.0-0.2ppm using the 200MHz gamma PRESS basis set. For more accurate measurements, we followed the guidelines of the software and measured the sum of glycerophosphocholine and phosphocholine (hereafter referred to as choline and abbreviated to cho), the sum of n-acetylaspartate and n-acetylaspartylglutatamate (hereafter referred to as aspartate, abbreviated to NAA), glutamate and glutamine (hereafter referred to as total glutamine-glutamate, abbreviated to Glx). In addition,
we measured the amino acid taurine. Metabolites were only considered for analysis where the standard deviation of modelling fits (Cramér-Rao lower bound) was lower than 20% in more than 90% of spectra acquired. For normalisation, metabolites were considered as ratios to the sum of creatine and phosphocreatine for each voxel. There is a caveat to our spectroscopy data, which is that the use of total creatine and phosphocreatine levels to normalise metabolite values could lead to confounded values if levels of creatine itself change. It is possible to use water levels as an alternative [31] . However, there is also a potential confound with this technique. Given the atrophy of the striatum, and the increased ventricular volume in the region of the 1 H-MRS voxel, it is possible that all metabolites would appear to be decreased in concentration as the visible water signal increases. Therefore, there are disadvantages to both techniques, so we chose the one that was less affected by physical changes in the brain.
Results
Life spans of R6/2 mice were similar to those of our previous reports, with R6/2 250 We used TBM to look for differences between the brains of male and female mice at 12-15 week. No significant sex differences were found, even when the threshold for statistical significance was raised to exploratory levels (controlling the false-discovery rate at p < 0.25; data not shown). Since there were no sex differences, we combined male and female data in further analyses. TBM analysis of brains of mice aged 12-15 weeks showed widespread reductions of volume in both lines of R6/2 mice compared to WT mice. R6/2 250 CAG mice showed more regions of significantly lower volume than were seen in R6/2 350 CAG mice ( Figure   2 ).The changes were predominantly in grey matter structures in both groups of mice.
In R6/2 250 CAG mice (Figure 2A) , several of the basal ganglia were reduced in volume, with highly significant clusters seen in the caudate putamen and substantia nigra, although no changes were detected in lateral parts of the globus pallidus. The cortex was also widely affected, with the most significant effects being seen in the frontal cortex and parietal cortices, to a lesser extent the temporal cortex, and with some apparent sparing of superior aspects to the occipital cortex. The hippocampal formation, and in particular the dentate gyrus, was also reduced in volume. The central grey matter was also affected. The cerebellum showed reduced volume, in particular the fifth and sixth lobes, while the brain stem and medulla were largely spared (Figure 2A ). At 12-15 weeks, atrophy in 350 CAG mice ( Figure 2B ) was less wide-spread than in the 250 CAG mice. Significant changes were seen mainly in the striatum, sensorimotor cortex, amygdala, and hippocampal formation. The differences in the hippocampus were focal, and centred on the CA2 subfield and dentate gyrus, compared to the more global changes seen in the hippocampal formation of 250 CAG mice. CAG mice all died prematurely of the disease. The use of TBM in this study enabled us to detect changes in tissues that are further from grey and white matter boundaries than would be possible using VBM alone as in our previous study [26] .
TBM showed that atrophy in the R6/2 cortex is not generalised, but rather is more prominent within discrete layers of the cortex in R6/2 mice, with the peripheral layers being least affected (Figure 4) .
Longitudinal ROI measurements
The analysis for sex differences showed a greater rate of volume increase in the lateral ventricles for CAG 350 female mice when compared to male mice (p < 0.002;
Supplementary Figure 1 ). There were no other significant differences in the rate of change of structures by sex. Significant longitudinal atrophy (p < 2×10-5) was seen in the cortex ( Figure 5A ), caudate putamen ( Figure 5B ), amygdaloid nucleus ( Figure   5D ), hippocampal formation ( Figure 5E ) and cerebellum ( Figure 5G ) in both the 250 and 350 CAG repeat R6/2 mice. As expected, the lateral ventricles significantly increased in volume in all R6/2 mice (p < 2×10-5, Figure 5C ). The internal capsule was unaffected ( Figure 5F ). When comparing data between R6/2 lines, a significant difference in rate of overall atrophy was seen for the cortex (p < 0.002, Figure 5A ), caudate (p<1×10 -5 , Figure 5B ), amygdaloid nucleus (p<2×10 -5 , Figure 5D ), hippocampal formation (p < 1×10 -5 , Figure 5E ), and cerebellum (p < 1×10 -5 , Figure   5G ), with atrophy in the 350 CAG mice being much slower. No significant changes were seen in the internal capsule (p = 0.3, Figure 5F ).
Metabolites
We measured the levels of four metabolites (NAA, Glx, cho, taurine), all of which showed age-dependent changes in one or both lines of R6/2 mice. Levels of the neuronal marker NAA decreased significantly with age in both R6/2 250 (p < 0.0002) and 350 CAG mice (p<0.01) when compared to WT mice ( Figure 6A ). Glx concentrations decreased with age faster in R6/2 than WT mice (250 CAG, p < 0.006 and 350 CAG, p < 0.002, Figure 6C ). Compared to WT mice, taurine increased significantly over time in both 250 and 350 CAG mice (p < 0.01 and p < 0.04 respectively, Figure 6D ). Interestingly, a significant decrease in choline concentration (p < 0.05) was seen in the R6/2 350 CAG mice but not the 250 CAG mice ( Figure 6B ).Comparing the R6/2 250 CAG and 350 CAG mice directly, significant differences were seen only for choline (p < 0.01) ( Figure 6B ). [18] .
Discussion
The unfavourable prognosis in HD patients and animal models in relation to longer CAG repeat lengths is widely reported [6, 32, 33] . However, evidence is accumulating to indicate that this is not a straightforward relationship, and that mouse models of HD with CAG repeat lengths over 200 have an ameliorated phenotype compared to mice with fewer repeats [18, 20, 21] . In this study, we used high resolution MRI, MRS and automated whole brain analysis to examine the development of neuronal atrophy in R6/2 mice with markedly different CAG repeat lengths, duration of disease and behavioural phenotypes. We compared directly R6/2 mice with 250 CAG repeats (that has a rapidly progressing disease) and 350 CAG repeats (that has an ameliorated phenotype and longer lifespan [18] [18, 20] or electrophysiology [21] . Each of these studies found that the correlation of CAG repeat length with worsening disease trajectories is overturned after a critical value: at some point the mice carrying more polyglutamine repeats in their transgenic HD gene have an increased life span and show a delayed phenotype of HD-like symptoms. Our current data fit well with these previous studies. For completeness, it would have been interesting to look at mice with shorter CAG repeats (e.g. 110 CAGs).
However, these mice have a very aggressive phenotype and very short lifespan, which makes longitudinal scanning with multiple anaesthesia sessions difficult.
We found no sex differences in rate of changes of brain structures in the 250 CAG mice, in accordance with our previous studies [22, 26, 29] . However, we did find that in the 350 CAG mice, lateral ventricles increased in size faster in female than male TG mice. This may be another manifestation of the differences in time course of changes between the two strains, i.e. there may be sex differences in the 250 CAG mice but they are so short-lived that they did not show up on our analysis.
It has been reported that there are sex differences in brain volumes in R6/2 mice with 210 CAG repeats [35] . The difference in results between our current study and that of Rattray et al. may be explained by differences in methodology -we used an automated analysis (TBM), while the Rattray study used manual volumetry. It is interesting to note that while we found no absolute differences in brain structures between male and female CAG 350 mice at the 12-15 week timepoint, we did detect differences between the sexes in the rate of change. This emphasises the value of a longitudinal analysis, which can detect changes that might otherwise be missed.
We have referred to the reduction in brain volumes we found in R6/2 mice as atrophy. However, it has been suggested that mutant huntingtin can also cause developmental dysfunction that contributes to neurodegeneration [36] . A study using BACHD mice has led to the proposition that HD pathology has two components, one developmental and the other resulting from the long-term toxic effects of mutant huntingtin [37] . While BACHD mice have a different genetic construct to R6/2 mice, we cannot rule out the possibility that at least some of the volume reduction we have observed is due to a developmental process.
Our MRS data showed progressive declines in NAA, glutamine/glutamate and an increase in taurine in both lines of R6/2 mice. As was seen with structural MRI, the rate of change was slower in 350 than 250 CAG mice. Decreased NAA has also been reported in HD patients [38] [39] [40] , and140-150 CAG R6/2 mice [41, 42] . Since levels of NAA may reflect the functional status of neuronal mitochondria [43] , the reduced levels of NAA we found in the R6/2 mice may reflect neuronal dysfunction.
Our findings of reduced glutamine/glutamate levels in both 250 and 350 CAG R6/2 mice reflect data from HD patients [44, 45] , and are consistent with the reduced glutamatergic signalling and receptor binding seen in symptomatic animals and humans [46, 47] . Increased taurine levels have been reported previously in 150 CAG R6/2 mice [42] , zQ175 knock-in mice [31] , and the APP mouse model of Alzheimer's disease [48] . Taurine protects against oxidative stress in the 3-NP model of HD [49] , is associated with apoptosis in brain tumours [50] , and helps regulate brain volume [51, 52] . It is possible that the elevated levels seen in models of HD (including those used here) are a homeostatic response to the widespread apoptosis and atrophy resulting from the phenotype. The reduction in choline levels that we found in 350 CAG R6/2 mice reflects data from 200 CAG R6/2 mice [53] and from HD patients, where a decrease in choline has been reported in the frontal cortex and putamen [40, 54] ). It has been suggested that cellular dysfunction preceding death may lead to reduced concentrations of choline [54] . This being the case, it is interesting that choline levels were lower in the 350 CAG but not the 250 CAG R6/2 mice. This may suggest a compensatory mechanism in the more severe form of the disease, or that the 250 CAG mice died before choline levels changed.
Either way, it would be interesting to study this further.
Taken together, our data show that although the overall pattern of atrophy is similar in the two strains, the underlying pathology has an extended timecourse in 350 CAG mice, which may contribute to their longer lifespan. It has been proposed that the aggressive phenotype in R6/2 mice with shorter repeats may be due to accumulation of mutant protein in the nucleus, and that the larger protein made in mice with longer repeats may be too big to enter the nucleus, leading to an amelioration of the phenotype [20] . approximately double that seen in 250 CAG mice [24] . They suggested that these abnormal structures found in DNA with very long CAG repeats may reduce transcription of the transgene [24] . It is possible, therefore, that as repeat lengths increase, production of mutant huntingtin decreases, leading to prolonged cell survival compared to cells containing DNA with shorter CAG repeats.
Our current study builds on our previous examination of ex vivo 18 week old R6/2 mice [26] . In this study we have greater sensitivity due to (a) improved in vivo contrast and preserved overall brain shape (without the damage or variability introduced by extraction of the brain from the skull and consequent loss of cerebrospinal fluid pressure post mortem) and (b) the fact that we used TBM as opposed to the voxel-based morphometry (VBM) we used in our previous work. The methodological advantage of TBM is that local volume changes are used to compare morphology, instead of modulated grey and white matter volume scores [27, 55] .
This avoids potential errors that may be caused by changes in the chemical properties of tissues within each voxel. For example, changes in water content affect signal intensity. Local changes in water content, which can occur as a result of pathological processes, could lead to voxels that would be classified by VBM as white matter in WT brain to be misclassified as grey matter in a transgenic brain.
Furthermore, and importantly for small brains such as those of mice, TBM is more sensitive than VBM to changes that are further from grey and white matter boundaries. This increased sensitivity allowed us to identify atrophy within layers of the cortex in R6/2 mice, while our earlier VBM study restricted our findings to atrophy of the cortex as a whole [26] .
Conclusion
We have compared, for the first time using in vivo longitudinal volumetric and 
